Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2026-02-04 @ 4:30 AM
Study NCT ID:
NCT02722161
Status:
COMPLETED
Last Update Posted:
2016-07-13
First Post:
2016-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olmutinib (BI 1482694) ADME Study
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: